|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| C07H 21/00 | |||
| A61K 31/7088 | |||
| A61P 25/00 |
| (11) | Number of the document | 2850190 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13791546.8 |
| Date of filing the European patent application | 2013-05-16 | |
| (97) | Date of publication of the European application | 2015-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/041394 |
| Date | 2013-05-16 |
| (87) | Number | WO 2013/173608 |
| Date | 2013-11-21 |
| (30) | Number | Date | Country code |
| 201261648051 P | 2012-05-16 | US |
| (72) |
KRIEG, Arthur, M., US
SUBRAMANIAN, Romesh, US
MCSWIGGEN, James, US
LEE, Jeannie, T., US
|
| (73) |
The General Hospital Corporation,
55 Fruit Street, Boston, MA 02114,
US
Translate Bio MA, Inc., 29 Hartwell Avenue, Lexington, MA 02421, US |
| (54) | COMPOSITIONS AND METHODS FOR MODULATING MECP2 EXPRESSION |
| COMPOSITIONS AND METHODS FOR MODULATING MECP2 EXPRESSION |